UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A

Thrombosis research, 2019-11, Vol.183, p.1-3

2019

Volltextzugriff (PDF)

Updates on Novel Non-Replacement Drugs for Hemophilia

Pharmaceuticals (Basel, Switzerland), 2022-09, Vol.15 (10), p.1183

2022

Volltextzugriff (PDF)

How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report

Journal of thrombosis and thrombolysis, 2020-11, Vol.50 (4), p.795-798

2020

Volltextzugriff (PDF)

Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia

Journal of clinical medicine, 2023-10, Vol.12 (20), p.6672

2023

Volltextzugriff (PDF)

Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect

Vaccines (Basel), 2024-07, Vol.12 (7), p.709

2024

Volltextzugriff (PDF)

Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients

Medicina (Kaunas, Lithuania), 2024-01, Vol.60 (1), p.34

2024

Volltextzugriff (PDF)

Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years

Blood transfusion = Trasfusione del sangue, 2019-09, Vol.17 (5), p.378-384

2019

Volltextzugriff (PDF)

Regenerative Surgery with Dental Implant Rehabilitation in a Haemophiliac Patient

TH open : companion journal to thrombosis and haemostasis, 2021-01, Vol.5 (1), p.e104-e106

2021

Volltextzugriff (PDF)

Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

Bleeding, Thrombosis and Vascular Biology, 2022-05, Vol.1 (2)

2022

Volltextzugriff (PDF)

Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry

Journal of clinical medicine, 2022-04, Vol.11 (7), p.1969

2022

Volltextzugriff (PDF)

Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives

Journal of blood medicine, 2022-01, Vol.13, p.191-199

Pasca, Samantha

2022

Volltextzugriff (PDF)

Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

Journal of clinical medicine, 2022-06, Vol.11 (12), p.3434

2022

Volltextzugriff (PDF)

Treatment With Efmoroctocog Alfa (Elocta®) in Hemophilia: A Case Series

Clinical management issues, 2020-10, Vol.14 (1)

2020

Volltextzugriff (PDF)

Haemophilia A/B carriers: haemorrhagic burden of disease and open issues

Blood transfusion = Trasfusione del sangue, 2020-11, Vol.18 (6), p.496-497

2020

Volltextzugriff (PDF)

Light and shadows of the new therapies for haemophilia treatment in the COVID-19 era

Blood transfusion = Trasfusione del sangue, 2021-01, Vol.19 (1), p.73-76

2021

Volltextzugriff (PDF)

Thrombophilic Mutations as Risk Factor for Retinal Vein Occlusion

Clinical and applied thrombosis/hemostasis, 2015-05, Vol.21 (4), p.373-377

2015

Volltextzugriff (PDF)

Specific serum biomarkers to assess the bone health in a group of hemophilia A carriers: Data from the CAR.BONE study

Thrombosis research, 2024-01, Vol.233, p.200-202

2024

Volltextzugriff (PDF)

The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison

Journal of thrombosis and thrombolysis, 2022-11, Vol.54 (4), p.593-596

2022

Volltextzugriff (PDF)

Prothrombin Complex Concentrate Such as Therapy and Prophylaxis in Factor X-Deficient Patient (Friuli Variant)

Clinical and applied thrombosis/hemostasis, 2011-08, Vol.17 (4), p.332-336

2011

Volltextzugriff (PDF)

PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A

Thrombosis research, 2017-09, Vol.157, p.58-63

2017

Volltextzugriff (PDF)

Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry

Thrombosis research, 2023-01, Vol.221, p.35-36

2023

Volltextzugriff (PDF)

Correction to: The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison

Journal of thrombosis and thrombolysis, 2023, Vol.55 (1), p.195-195

2023

Volltextzugriff (PDF)

Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review

Drug design, development and therapy, 2022-01, Vol.16, p.3109-3116

2022

Volltextzugriff (PDF)

Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry

JAMA internal medicine, 2015-09, Vol.175 (9), p.1474

2015

Volltextzugriff (PDF)

Successful of Immune Tolerance Induction (R-ITI) with Simoctocog Alfa (rhFVIII) in Hemophilia a Patients and High-Titer Inhibitors

Blood, 2018-11, Vol.132 (Supplement 1), p.5036-5036

2018

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(93)
Berichte
(1)

Sprache

Englisch
(94)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Savings without changing: How to use the MyPKfit® device to improve treatment strategies in a cohort of patients with haemophilia A

Updates on Novel Non-Replacement Drugs for Hemophilia

How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report

Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia

Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect

Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients

Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years

Regenerative Surgery with Dental Implant Rehabilitation in a Haemophiliac Patient

Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry

Concizumab as a Subcutaneous Prophylactic Treatment Option for Patients with Hemophilia A or B: A Review of the Evidence and Patient's Perspectives

Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

Treatment With Efmoroctocog Alfa (Elocta®) in Hemophilia: A Case Series

Haemophilia A/B carriers: haemorrhagic burden of disease and open issues

Light and shadows of the new therapies for haemophilia treatment in the COVID-19 era

Thrombophilic Mutations as Risk Factor for Retinal Vein Occlusion

Specific serum biomarkers to assess the bone health in a group of hemophilia A carriers: Data from the CAR.BONE study

The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison

Prothrombin Complex Concentrate Such as Therapy and Prophylaxis in Factor X-Deficient Patient (Friuli Variant)

PK-driven prophylaxis versus standard prophylaxis: When a tailored treatment may be a real and achievable cost-saving approach in children with severe hemophilia A

Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry

Correction to: The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTORTM2 trial to a real-world study: a head-to-head comparison

Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review

Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry

Successful of Immune Tolerance Induction (R-ITI) with Simoctocog Alfa (rhFVIII) in Hemophilia a Patients and High-Titer Inhibitors

Aktive Filter

Suchergebnisse filtern